Activation of 5-hydroxytryptamine-1A receptors suppresses cardiovascular responses evoked from the paraventricular nucleus

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 301, Issue 4, 2011, Pages

  Horiuchi, Jouji ^a   Atik, Alp ^a   Iigaya, Kamon ^a   McDowall, Lachlan M ^a   Killinger, Suzanne ^a   Dampney, Roger A L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Blood pressure; Dorsomedial hypothalamus; Heart rate; Renal sympathetic activity

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BICUCULLINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MICROINJECTION; NERVE CONDUCTION; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; TACHYCARDIA;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BLOOD PRESSURE; HEART RATE; KIDNEY; MALE; MODELS, ANIMAL; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SYMPATHETIC NERVOUS SYSTEM;

EID: 80053628008     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00144.2011     Document Type: Article

References (49)

1. Allen AM. Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension 39: 275-280, 2002.
2. Aston-Jones G, Akaoka H, Charlety P, Chouvet G. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11: 760-769, 1991.
3. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152, 1999.
4. Benarroch EE. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 15: 254-263, 2005.
5. Cao WH, Fan W, Morrison SF. Medullary pathways mediating specific sympathetic responses to activation of dorsomedial hypothalamus. Neuroscience 126: 229-240, 2004.
6. Coote JH. A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol 90: 169-173, 2005.
7. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74: 323-364, 1994.
8. Dampney RAL, Coleman MJ, Fontes MAP, Hirooka Y, Horiuchi J, Li YW, Polson JW, Potts PD, Tagawa T. Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin Exp Pharmacol Physiol 29: 261-268, 2002.
9. DiMicco JA, Samuels BC, Zaretskaia MV, Zaretsky DV. The dorsomedial hypothalamus and the response to stress: part renaissance, part revolution. Pharmacol Biochem Behav 71: 469-480, 2002.
10. DiMicco JA, Sarkar S, Zaretskaia MV, Zaretsky DV. Stress-induced cardiac stimulation and fever: common hypothalamic origins and brainstem mechanisms. Auton Neurosci 126-127: 106-119, 2006.
11. Dimicco JA, Zaretsky DV. The dorsomedial hypothalamus: a new player in thermoregulation. Am J Physiol Regul Integr Comp Physiol 292: R47-R63, 2007.
12. Dogrul A, Seyrek M. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br J Pharmacol 149: 498-505, 2006.
13. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 35, Suppl 4: S1-S7, 2000.
14. Ferguson AV, Latchford KJ, Samson WK. The paraventricular nucleus of the hypothalamus-a potential target for integrative treatment of autonomic dysfunction. Expert Opin Ther Targets 12: 717-727, 2008.
15. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73: 337-353, 1996.
16. Fontes MAP, Tagawa T, Polson JW, Cavanagh SJ, Dampney RAL. Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am J Physiol Heart Circ Physiol 280: H2891-H2901, 2001.
17. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol 281: 81-88, 1995.
18. Fozard JR, Mir AK, Middlemiss DN. Cardiovascular response to 8-hydroxy- 2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol 9: 328-347, 1987.
19. Geerling JC, Shin JW, Chimenti PC, Loewy AD. Paraventricular hypothalamic nucleus: axonal projections to the brainstem. J Comp Neurol 518: 1460-1499, 2010.
20. Gradin K, Pettersson A, Hedner T, Persson B. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HTreceptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transm 62: 305-319, 1985.
21. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
22. Helke CJ, Capuano S, Tran N, Zhuo H. Immunocytochemical studies of the 5-HT1A receptor in ventral medullary neurons that project to the intermediolateral cell column and contain serotonin or tyrosine hydroxylase immunoreactivity. J Comp Neurol 379: 261-270, 1997.
23. Horiuchi J, McAllen RM, Allen AM, Killinger S, Fontes MAP, Dampney RAL. Descending vasomotor pathways from the dorsomedial hypothalamic nucleus: role of medullary raphé and RVLM. Am J Physiol Regul Integr Comp Physiol 287: R824-R832, 2004.
24. Horiuchi J, Wakabayashi S, Dampney RAL. Activation of 5-hydroxytryptamine 1A receptors suppresses the cardiovascular response evoked from the dorsomedial hypothalamic nucleus. Hypertension 46: 173-179, 2005.
25. Jordan D. Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol 90: 175-181, 2005.
26. Kenney MJ, Weiss ML, Patel KP, Wang Y, Fels RJ. Paraventricular nucleus bicuculline alters frequency components of sympathetic nerve discharge bursts. Am J Physiol Heart Circ Physiol 281: H1233-H1241, 2001.
27. Liu Q, Wong-Riley MTT. Postnatal changes in the expressions of serotonin 1A, 1B, and 2A receptors in ten brain stem nuclei of the rat: implication for a sensitive period. Neuroscience 165: 61-78, 2010.
28. Marvin E, Scrogin K, Dudas B. Morphology and distribution of neurons expressing serotonin 5-HT1A receptors in the rat hypothalamus and the surrounding diencephalic and telencephalic areas. Chem Neuroanat 39: 235-241, 2010.
29. McCall RB, Clement ME. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 46: 231-243, 1994.
30. McCall RB, Clement ME, Harris LT. Studies on the mechanism of the sympatholytic effect of 8-OH DPAT: lack of correlation between inhibition of serotonin neuronal firing and sympathetic activity. Brain Res 501: 73-83, 1989.
31. McCall RB, Patel BN, Harris LT. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther 242: 1152-1159, 1987.
32. Morrison SF, Nakamura K, Madden CJ. Central control of thermogenesis in mammals. Exp Physiol 93: 773-797, 2008.
33. Nalivaiko E, Ootsuka Y, Blessing WW. Activation of 5-HT1A receptors in the medullary raphé reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits. Am J Physiol Regul Integr Comp Physiol 289: R596-R604, 2005.
34. Nalivaiko E, Sgoifo A. Central 5-HT receptors in cardiovascular control during stress. Neurosci Biobehav Rev 33: 95-106, 2009.
35. Ngampramuan S, Baumert M, Beig MI, Kotchabhakdi N, Nalivaiko E. Activation of 5-HT1A receptors attenuates tachycardia induced by restraint stress in rats. Am J Physiol Regul Integr Comp Physiol 294: R132-R141, 2008.
36. Nosjean A, Guyenet PG. Role of ventrolateral medulla in sympatholytic effect of 8-OHDPAT in rats. Am J Physiol Regul Integr Comp Physiol 260: R600-R609, 1991.
37. Ootsuka Y, Blessing WW. 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits. J Physiol 552: 303-314, 2003.
38. Ootsuka Y, Blessing WW. Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits. Brain Res 1073-1074: 252-261, 2006.
39. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
40. Patel KP. Role of paraventricular nucleus in mediating sympathetic outflow in heart failure. Heart Fail Rev 5: 73-86, 2000.
41. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. (4th ed.) New York: Academic, 1998.
42. Ramage AG, Fozard JR. Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats. Eur J Pharmacol 138: 179-191, 1987.
43. Samuels BC, Zaretsky DV, DiMicco JA. Dorsomedial hypothalamic sites where disinhibition evokes tachycardia correlate with location of raphé-projecting neurons. Am J Physiol Regul Integr Comp Physiol 287: R472-R478, 2004.
44. Saper CB, Loewy AD, Swanson LW, Cowan WM. Direct hypothalamoautonomic connections. Brain Res 117: 305-312, 1976.
45. Shaffer JP. Modified sequentially rejective multiple test procedures. J Am Stat Assoc 81: 826-831, 1986.
46. Swanson LW, Sawchenko PE. Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31: 410-417, 1980.
47. Thor KB, Nickolaus S, Helke CJ. Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord. Neuroscience 55: 235-252, 1993.
48. van den Buuse M, Wegener N. Involvement of serotonin1A receptors in cardiovascular responses to stress: a radio-telemetry study in four rat strains. Eur J Pharmacol 507: 187-198, 2005.
49. Vianna DM, Carrive P. Inhibition of the cardiovascular response to stress by systemic 5-HT1A activation: sympathoinhibition or anxiolysis? Am J Physiol Regul Integr Comp Physiol 297: R495-R501, 2009.